P2X7 is a cytotoxic receptor.maybe not: implications for cancer

Francesco Di Virgilio1

  • 1Department of Medical Sciences, University of Ferrara, Ferrara, Italy. fdv@unife.it.

Purinergic Signalling
|October 4, 2020
PubMed

Insights

Extracellular ATP in tumors impacts cancer and immune cells via P2X7 receptors. Its breakdown to adenosine creates an immunosuppressive environment, a key finding influenced by purinergic research.

Area of Science:

  • Immunology
  • Cancer Biology
  • Pharmacology

Background:

  • The tumor microenvironment (TME) contains high levels of extracellular adenosine triphosphate (ATP).
  • ATP influences cancer cell behavior and immune cell responses through purinergic receptors, particularly P2X7.
  • Adenosine, a potent immunosuppressant, is generated from ATP degradation in the TME.

Purpose of the Study:

  • To appraise the influence of Geoff Burnstock's purinergic hypothesis on cancer research.
  • To highlight the critical role of the P2X7 receptor in cancer immunity.
  • To discuss the author's own research inspired by purinergic signaling.

Main Methods:

  • Review of existing literature on purinergic signaling in cancer.
  • Analysis of experimental findings related to P2X7 receptor function.
  • Personal reflection on research trajectory influenced by purinergic concepts.

Main Results:

  • Extracellular ATP and its metabolite adenosine significantly modulate the TME.
  • The P2X7 receptor is a key mediator of ATP's effects on cancer and immune cells.
  • Purinergic signaling provides a framework for understanding TME complexity.

Conclusions:

  • Geoff Burnstock's purinergic hypothesis has been instrumental in advancing cancer research.
  • Targeting the P2X7 receptor presents a potential therapeutic strategy in oncology.
  • Understanding purinergic pathways is crucial for developing novel cancer immunotherapies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K